LOGO
LOGO

FDA Calendar - Sanofi SA

Company Name Sanofi SA
SNY, SNYNF, SAN.PA
Drug Name Tzield (sBLA)
Event Name FDA decision on Tzield to expand to as young as one year old and above to delay the onset of stage 3 type 1 diabetes in patients diagnosed with stage 2 T1D
Event Date 04/29/2026
Outcome Date 04/22/2026
Outcome FDA approved Tzield to delay the onset of stage 3 type 1 diabetes in patients diagnosed with stage 2 T1D in children aged one year and above on Apr.22, 2026
Drug Status Priority review

FDA accepted for priority review the supplemental biologic license application (sBLA) for Tzield (teplizumab-mzwv) to expand the current age indication from eight years and above, to as young as one year old and above to delay the onset of stage 3 type 1 diabetes (T1D) in patients diagnosed with stage 2 T1D.

If approved, Tzield would be the first disease-modifying therapy to delay the onset of stage 3 T1D in children aged one and older diagnosed with stage 2 T1D.
Rival Drugs
Market Potential
Other Approvals Tzield was first approved in the US in November 2022 to delay the onset of stage 3 T1D in adults and children eight years and older diagnosed with stage 2 T1D. Today, it is also approved in China, the UK, Canada, Israel, the Kingdom of Saudi Arabia, the United Arab Emirates, and Kuwait for the same indication.

In November 2025, the European Medicines Agency’s Committee for Medicinal Products for Human Use issued a positive recommendation for the same population. Other regulatory reviews are ongoing.
News
FDA Accepts Sanofi's Tzield SBLA Priority Review To Expand Use In Children 1+ For Type 1 Diabetes
Return to FDA Calendar
Editors Pick
inditex 03062026 lt

Inditex Stock Gains On Growth In Q1 Results, Q2-to-date Sales On Strong Demand

June 03, 2026 07:48 ET
dollargeneralcorp 02062026 lt

Dollar General Lifts FY26 Profit View After Strong Q1, Backs Sales Forecast

June 02, 2026 09:54 ET
prime 02062026 lt

Amazon's Prime Day Event On June 23-26 With Millions Of Deals

June 02, 2026 02:35 ET
dollartree 28052026 lt

Dollar Tree Stock Up 13% On Q1 Results, Positive Outlook, Deal With DoorDash

May 28, 2026 08:13 ET
Copyright © 2026 RTTNews. All rights reserved. By using this site, you agree to the Terms of Service. About Us   |   Contact Us   |   Privacy   |   Sitemap